• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过免疫信息学和系统生物学方法预测和验证针对单纯疱疹病毒 1 的有效肽。

Prediction and validation of potent peptides against herpes simplex virus type 1 via immunoinformatic and systems biology approach.

机构信息

State Key Laboratory of Microbial Metabolism, College of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.

出版信息

Chem Biol Drug Des. 2019 Sep;94(5):1868-1883. doi: 10.1111/cbdd.13602. Epub 2019 Sep 12.

DOI:10.1111/cbdd.13602
PMID:31437863
Abstract

The human herpes simplex virus type 1 (HSV-1) is an extremely rampant human pathogen, and its infection could cause life-long diseases, including the central nervous system disorders. The glycoproteins of HSV-1 such as glycoprotein B, glycoprotein C, glycoprotein D, glycoprotein H, and glycoprotein L are highly involved in mediating the viral attachment and infection of the host cell. Therefore, immunoinformatic approaches followed by molecular dynamics simulation and systems biology has been used to analyze these glycoproteins in order to propose effective peptide-based vaccine candidates against the HSV-1 infection. The ElliPro and NetCTL.1.2 online tools were employed to forecast the B- and T-lymphocyte (CTL) epitopes for gB, gC, gD, gH, and gL. The 3D coordinates of these epitopes were modeled and docked against the human major histocompatibility complex molecule-1. The outcomes obtained from postdocking analysis along with TAP (Transporter associated with antigen processing), MHC binding, and C-terminal cleavage score assisted in the selection of potential epitopes. These epitopes were further subjected to molecular dynamics simulation and systems biology approach which showed significant results. On the basis of these substantial outcomes, peptides are proposed that could be used to provoke immunity against the HSV-1 infection.

摘要

单纯疱疹病毒 1 型(HSV-1)是一种极其猖獗的人类病原体,其感染可导致终身疾病,包括中枢神经系统疾病。HSV-1 的糖蛋白,如糖蛋白 B、糖蛋白 C、糖蛋白 D、糖蛋白 H 和糖蛋白 L,高度参与介导病毒对宿主细胞的附着和感染。因此,采用免疫信息学方法,结合分子动力学模拟和系统生物学,分析这些糖蛋白,以提出针对 HSV-1 感染的有效基于肽的疫苗候选物。使用 ElliPro 和 NetCTL.1.2 在线工具来预测 gB、gC、gD、gH 和 gL 的 B 细胞和 T 细胞(CTL)表位。这些表位的 3D 坐标被建模,并对接至人类主要组织相容性复合体分子-1。对接分析的结果以及 TAP(抗原加工转运体)、MHC 结合和 C 末端切割评分辅助选择潜在的表位。这些表位进一步进行分子动力学模拟和系统生物学分析,结果显著。基于这些实质性结果,提出了一些肽,可用于引发针对 HSV-1 感染的免疫。

相似文献

1
Prediction and validation of potent peptides against herpes simplex virus type 1 via immunoinformatic and systems biology approach.通过免疫信息学和系统生物学方法预测和验证针对单纯疱疹病毒 1 的有效肽。
Chem Biol Drug Des. 2019 Sep;94(5):1868-1883. doi: 10.1111/cbdd.13602. Epub 2019 Sep 12.
2
Immunoinformatic and systems biology approaches to predict and validate peptide vaccines against Epstein-Barr virus (EBV).免疫信息学和系统生物学方法预测和验证针对 Epstein-Barr 病毒 (EBV) 的肽疫苗。
Sci Rep. 2019 Jan 24;9(1):720. doi: 10.1038/s41598-018-37070-z.
3
Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.从单纯疱疹病毒糖蛋白D中鉴定出具有保护性免疫作用的新型免疫显性CD4+ Th1型T细胞肽表位。
J Virol. 2003 Sep;77(17):9463-73. doi: 10.1128/jvi.77.17.9463-9473.2003.
4
HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D.从单纯疱疹病毒糖蛋白D中鉴定出的HLA - A*0201限制性CD8 + 细胞毒性T淋巴细胞表位
J Immunol. 2008 Jan 1;180(1):426-37. doi: 10.4049/jimmunol.180.1.426.
5
Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8 T and T Cell Responses against Herpesvirus Infection and Disease.激光辅助肽疫苗促进树突状细胞向皮肤迁移,并增强针对疱疹病毒感染和疾病的保护性CD8 T细胞和T细胞反应。
J Virol. 2018 Mar 28;92(8). doi: 10.1128/JVI.02156-17. Print 2018 Apr 15.
6
Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D.从单纯疱疹病毒1型糖蛋白D中鉴定出的性别依赖性HLA - DR限制性表位。
Clin Vaccine Immunol. 2008 Sep;15(9):1436-49. doi: 10.1128/CVI.00123-08. Epub 2008 Jul 30.
7
Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.用单纯疱疹病毒1型糖蛋白D衍生的“无症状”人CD8 + T细胞表位混合物进行治疗性免疫可减少潜伏感染的HLA转基因兔的自发性眼部排毒:与局部PD-1 + TIM-3 + CD8 +耗竭性T细胞的低频率相关。
J Virol. 2015 Jul;89(13):6619-32. doi: 10.1128/JVI.00788-15.
8
Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.从单纯疱疹病毒皮层蛋白VP13/14(UL47)中鉴定出的人类无症状表位优先召回多功能效应记忆CD44高CD62L低CD8 + TEM细胞,并保护人源化HLA - A*02:01转基因小鼠免受眼部疱疹病毒感染。
J Virol. 2017 Jan 3;91(2). doi: 10.1128/JVI.01793-16. Print 2017 Jan 15.
9
Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunisation with herpes simplex virus type-1 genes specifying glycoproteins gB and gD.通过用指定糖蛋白gB和gD的1型单纯疱疹病毒基因进行核酸免疫,使小鼠对致死性1型单纯疱疹病毒攻击产生保护性免疫。
J Med Microbiol. 2002 Apr;51(4):350-357. doi: 10.1099/0022-1317-51-4-350.
10
Functional Characterization of Glycoprotein H Chimeras Composed of Conserved Domains of the Pseudorabies Virus and Herpes Simplex Virus 1 Homologs.由伪狂犬病病毒和单纯疱疹病毒1同源物保守结构域组成的糖蛋白H嵌合体的功能特性
J Virol. 2015 Oct 21;90(1):421-32. doi: 10.1128/JVI.01985-15. Print 2016 Jan 1.

引用本文的文献

1
Network toxicology reveals glyphosate mechanisms in kidney injury and cancer​​.网络毒理学揭示了草甘膦在肾损伤和癌症中的作用机制。
Sci Rep. 2025 Aug 24;15(1):31132. doi: 10.1038/s41598-025-17067-1.
2
Deciphering the role of cell signaling pathways in gout pathogenesis and the therapeutic potential of phytoconstituents in their modulation.解析细胞信号通路在痛风发病机制中的作用以及植物成分在调节这些通路方面的治疗潜力。
Inflammopharmacology. 2025 Apr 18. doi: 10.1007/s10787-025-01741-x.
3
Multi-epitope-based vaccine models prioritization against Astrovirus MLB1 using immunoinformatics and reverse vaccinology approaches.
基于多表位的疫苗模型针对星状病毒MLB1的免疫信息学和反向疫苗学方法优先排序
J Genet Eng Biotechnol. 2025 Mar;23(1):100451. doi: 10.1016/j.jgeb.2024.100451. Epub 2024 Dec 16.
4
Computer aided design of inhibitor molecules against Vpr protein from different HIV-1 subtypes.针对不同HIV-1亚型的Vpr蛋白的抑制剂分子的计算机辅助设计
In Silico Pharmacol. 2025 Feb 8;13(1):23. doi: 10.1007/s40203-025-00318-4. eCollection 2025.
5
Computational biology assisted exploration of phytochemicals derived natural inhibitors to block BZLF1 gene activation of Epstein-Bar virus in host.计算生物学辅助探索植物化学物质衍生的天然抑制剂,以阻断宿主中爱泼斯坦-巴尔病毒的BZLF1基因激活。
Sci Rep. 2024 Dec 30;14(1):31664. doi: 10.1038/s41598-024-81037-2.
6
Immunological Considerations for the Development of an Effective Herpes Vaccine.开发有效疱疹疫苗的免疫学考量
Microorganisms. 2024 Sep 6;12(9):1846. doi: 10.3390/microorganisms12091846.
7
Peptide based vaccine designing against endemic causing mammarenavirus using reverse vaccinology approach.采用反向疫苗学方法设计针对引起地方病的沙粒病毒的肽基疫苗。
Arch Microbiol. 2024 Apr 15;206(5):217. doi: 10.1007/s00203-024-03942-4.
8
Repurposing of drugs targeting heparan sulphate binding site of dengue virus envelope protein: an in silico competitive binding study.靶向登革病毒包膜蛋白硫酸乙酰肝素结合位点的药物重新利用:一项计算机模拟竞争性结合研究。
Mol Divers. 2025 Feb;29(1):87-101. doi: 10.1007/s11030-024-10834-8. Epub 2024 Apr 3.
9
Genomic annotation for vaccine target identification and immunoinformatics-guided multi-epitope-based vaccine design against Songling virus through screening its whole genome encoded proteins.通过筛选 Songling 病毒全基因组编码蛋白进行疫苗靶标鉴定的基因组注释和免疫信息学指导的多表位疫苗设计。
Front Immunol. 2023 Nov 28;14:1284366. doi: 10.3389/fimmu.2023.1284366. eCollection 2023.
10
Annotation of Potential Vaccine Targets and Designing of mRNA-Based Multi-Epitope Vaccine against Lumpy Skin Disease Virus via Reverse Vaccinology and Agent-Based Modeling.基于反向疫苗学和基于主体建模的牛结节性皮肤病病毒潜在疫苗靶点注释及基于mRNA的多表位疫苗设计
Bioengineering (Basel). 2023 Mar 28;10(4):430. doi: 10.3390/bioengineering10040430.